Articles tagged with Reperfusion
A clinical trial found that a device used to clear debris in arteries during PCI did not provide benefits for patients. Despite successful retrieval of embolic debris, the device failed to enhance myocardial reperfusion success, reduce infarct size, or improve clinical outcomes.
Researchers found significant racial and ethnic differences in time to fibrinolytic therapy and percutaneous coronary intervention. After adjusting for hospital differences, the disparities remained significant, highlighting the need for systemic changes to ensure high-quality hospitals for all patients.
Following guidelines improved acute reperfusion and adjunctive treatment of STEMI in diabetics, leading to a 36% relative reduction in hospital mortality. Diabetes mellitus significantly increases the risk of developing coronary artery disease.
A comprehensive analysis of 23 trials involving 7700 patients found primary angioplasty to be superior to thrombolytic therapy in reducing short-term death, non-fatal heart attacks, and strokes. The benefits were sustained over longer-term follow-up.
An international study reveals that up to a third of patients with severe heart attacks may not receive reperfusion therapy, despite its well-known benefits. The study highlights variation in treatment practices and identifies factors contributing to underuse, including patient age, medical history, and geographical location.
Researchers at Kansas State University have identified a protein called PR-39 that can suppress the production of toxic oxygen metabolites involved in reperfusion injury. The substance may hold promise as an anti-inflammatory fighter, potentially preventing tissue damage associated with blocked blood vessels.